Blood glucose increased: FDA reporting patterns
186,650 FDA FAERS reports mention Blood glucose increased. 75,239 reports have a serious outcome flag.
Medicines named as suspect
- Insulin Lispro: 36,418 reports
- Insulin Glargine: 24,041 reports
- Exenatide: 17,982 reports
- Insulin Human: 11,339 reports
- Dulaglutide: 9,313 reports
- Metformin: 8,112 reports
- Insulin Aspart: 6,474 reports
- Liraglutide: 3,336 reports
- Insulin Detemir: 3,335 reports
- Sitagliptin: 3,327 reports
- Solostar: 3,193 reports
- Insulin Degludec: 3,047 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.